Go to main Forum page »
“I’m giving you a love that’s true
And gonna make you love me, too
So get ready, get ready
‘Cause here I come.”
adapted from “Get Ready”
The Temptations, 1966
The Motown rhythm and blues quartet may well have divined the arrival of actively managed exchange-traded funds (ETFs). Can’t stop them now, ladies and gentlemen—they’re already here.
Leave it to the frantic asset managers who brought you the load fund and then repackaged it as no load with hidden excessive fees to invent a product to compete with the fabulously successful passive (or index) ETF. The fund purveyors needed to staunch the flow of assets from their high-fee mutual funds to passive ETFs and to convert their longstanding lucrative investment vehicle into one less profitable but more in demand.
A few members of the board arranged in plush leather chairs around a conference table devised a new portfolio wrapper to become known as the active ETF. The creation would combine the best features of passive ETFs—low cost, tax efficiency, flexible trading and transparency. Giddy with their redemption, the executives proceeded to resurrect those tactical acrobats of yesteryear called portfolio managers. They would attract investors alarmed by their absence in passive ETFs.
According to one prominent provider of active ETFs, these trading magicians would “uncover market opportunities and select investments with the goal of outperformance rather than merely tracking an index.” To sweeten the pot, active ETFs would come with a strategically placed price in between that of the inexpensive passive fund and of the exorbitant mutual fund.
Just how menacing is the active incursion onto the ETF landscape? Well, aggressively promoted by the asset management companies, it’s burgeoned beyond all expectation. The number of active ETFs has grown exponentially in the last five years from barely 600 to almost 2,500. Likewise, assets under management have ballooned from about 50 billion to almost 900. Distressingly, about 80% of recent ETF launches had a portfolio manager at the helm. The active ETF phenomenon is a juggernaut.
But is the new vehicle an improvement or even any good at all? Specifically, how does its performance stack up against the formidable passive index fund? I thought I would clarify some of the differences between the two fund types and do an illustrative back-of-the-envelope demonstration of comparative performance.
I first consulted Morningstar’s list of the 28 best active ETFs to buy in 2025 based largely on their proprietary quantitative and analyst ratings. I then selected an active ETF from the T. Rowe Price mutual fund group, a leading provider which earned five of the 28 slots and with which I am familiar. I set out to analyze the Price Growth Stock ETF (TGRW) because of its pedigree and the ready availability of the Vanguard S&P 500 Growth ETF (VOOG) as the passive benchmark.
Let’s start out with an overview of the two contestants. Not surprisingly, both ETFs are classified by Morningstar as covering large growth territory. VOOG has been around a lot longer than recently launched Price Growth and as you might expect it’s a whole lot bigger. The former’s net assets are currently 15 billion as against the latter’s barely a billion. It is also much better diversified, holding about 200 stocks as compared to 60. In addition, the Vanguard portfolio is considerably less concentrated, having a 53% weighting as opposed to 64% in its top ten stocks. As befits growth funds in the recent market environment, both of these carry a high tech position, but Vanguard’s is notably smaller (about 40% rather than 50%).
We have here two funds that are quite similar, but the portfolio manager at Price has taken a more aggressive stance to achieve outperformance. So what happened?
I contrasted the funds’ results in the calamitous 2022 market and the recovery in 2023. During the sharp decline, the somewhat less risky VOOG proved its mettle, dropping about 30% as its adversary plunged 10% more. This pattern was reversed in the following year’s tech-led burst, rewarding the Growth ETF’s manager for his daring.
But what about this year? How have these two ETFs fared in our chaotic market? The data are not eye-opening but a discussion of the trends is instructive. As of mid-March, VOOG and TGRW) lost 8.9% and 10.2%, respectively. Several factors might be at work here. The expense ratio of Price’s growth ETF is .52, modestly below the expense of its mutual fund sibling but unconscionable in relation to VOOG’s .07 cost. Another contributor to the difference in performance may be TGRW’s much higher annual turnover rate of 50%. Its manager has incurred high trading expenses as a consequence of his frenetic quest for outperformance.
Do I hear somebody chortling in the back of the class that the difference in the year-to-date results (10.2% for VOOG, 8.9% for TGRW) practically-speaking insignificant. I would reply that it’s anything but insignificant if it were to persist in a long-term investment plan. Say you’re 45, planning to retire in 20 years and boast a half a million appreciating in an IRA. Further imagine your son needs long-term care, so you won’t be able to make any more contributions. How much will that half million grow to at 8.9% vs. 10.2%?
With the help of the compound interest calculator at investors.gov, we learn that the seemingly small difference in the two rates yields a stark contrast in returns. The lower rate produces a 3.0 million account balance at age 65, whereas the higher rate yields a final figure of 3.8 million. I submit that an $800,000 difference is indeed significant. Now recall the .45 discrepancy in cost of the two ETFs that will most likely hold about steady across time. Holders of Vanguard’s S&P 500 Growth ETF have that advantage locked in for the duration of their retirement plan.
Now let’s all calm down. This is more a demonstration than it is an upstanding piece of research. The numbers are true, but the time periods are woefully short. To be sure, this is not only a T. Rowe Price problem. It’s endemic to the active fund industry. We will have to “get ready” for the deeper penetration of the active myth into the ETF marketplace. That makes it all the more imperative to fend off for ourselves, our family and our friends the overblown promises of the financial services profession that benefits mightily from all the hoopla. To paraphrase those rhythm and blues lyrics, they want to make you love them, too.
It seems pointless to compare two funds that clearly have different holdings and asset allocation strategies, and then try to divine whether a difference in fees can explain a difference in performance. It won’t work.
And, estimating long term differences in return based on 1 year numbers is just plain pointless.
Same index funds, different wrappers, one of which we call “active” with a higher fee, there’s likely to be little mystery as to which of these funds will have achieved better long term performance.
I spent my career in the investment business and we spent most of our time trying to invent and sell “sizzle” to our clients. There were times when a new product or approach could produce outsized returns, but any such gains usually disappeared when everyone else jumped on the bandwagon. In the end, our performance, adjusted for fees, never matched our sales pitch and perhaps the best service we provided our clients was to restrain them from making even worse investment decisions than we did.
In retirement, I only hold low cost index funds and find little to recommend in a so-called “active” ETF.
Calling AVUV an active ETF is really just semantics. All ETFs use some sort of weighting methodology, such as market capitalization. Value funds use a universe of stocks that fit this term, such as price to book ratio, profitability, price to earnings ratio, etc. AVUV is a small cap value fund, so its weightings reflect that. It happens to weight small size a bit more than other similar funds, so its market capitalization is lower than many otherwise similar funds. Very small size value funds are quite undervalued at this point.
All the banter and negativity over the word “active” seems misplaced. AVUV is a completely rules based small cap value fund. Surely there are more pressing issues to debate.
I always compare the portfolio holdings when comparing ETFs. Sometimes it seems like splitting hairs; which companies do I favor? Furthermore, on a percentage basis TGRW holds 64% of the assets in the top ten holdings while VOOG is 51%. That 13% difference indicates that TGRW is somewhat more concentrated.
Then we’re in complete agreement.
Steve, is there a typo going from TGRW to FGRW? FGRW is referenced several times after first mentioning TGRW, and I don’t find any ETF name FGRW. Just curious.
Olin,
whoops, it’s TGRW. Thanks for catching my error. I’m going to try to edit the error out.
I always enjoy your creative writing, it keeps me interested and entertained.
Such a nice thing to say. Thank you.
Entertaining and Educational, both. Thank you.
And thank you.
I’ve never bought an actively managed ETF. In fact, I can’t even recall reading about a single active ETF that intrigued me. Am I missing out? Is there an active ETF that at least warrants consideration?
Take it from this newly frustrated Don Quixote of ETF outperformance, no need to fret. I’ve had a predictably fleeting affair with the small cap value fund run by Avantis, a recent offspring of American (formerly Twentieth) Century. The fund has been around for about five years and attracted a lot of money because of persistent outperformance relative to peers and a bargain-basement .25 active fee. Surely, my quest was over, I had found the Holy Grail! So far this year I am watching the devastation wrought by regression-to-the-mean. AVUV is performing at the lowest decile.
You may remember I had a hankering for Morningstar Wide Moat ETF, which had managed to beat the S&P over several years. We agreed that MOAT may simply have been a chance outlier fund destined for moderation. Judging by its more recent results, we may have been right. Last year, It fell to the 95th percentile of similar funds and is still operating below par.
No, Jonathan, you haven’t missed a thing—at least not anything I’ve come across. Of course, if I do find something, you know I’ll shout it from the mountaintop!
Interesting comment on AVUV which is recommended as best in class 2025 ETF for small cap value by Paul Merriman Foundation. They go through a pretty exhaustive evaluation to arrive at their recommendations, link to their video presentation below.
https://m.youtube.com/watch?v=YGIUrs2Vsmc
Hi Grant
I hope you get this second response to your question because on second thought it was too narrow. The presentation was very sophisticated and the emphasis on investing for the long term spot on. You are in good hands. My quibble is with the assumption that the pattern of future performance will necessarily return to the pattern of the past. That’s often not the case—small caps and value stocks have been poor performers for many years. Maybe the current valuation is accurate and the past was an overvaluation! Small cap value seems to make sense now, but it is in no way certain that AVUV will ultimately be one of the top performers in its class. But again, on Merriman’s emphasis on the long term, staying diversified and keeping costs down, I’m on board. It’s just at the level of predicting which funds will be outperformers I take some issue (as does Morningstar).
I’m sorry that my first response now strikes me as too negative and I hope you will find it.
Steve
Steve,
thank you for replying to my comment. I did not take your comments as overly negative.
I am not necessarily cheerleading one ETF vs another but was interested in hearing your/another opinion on AVUS which, as mentioned in my comment, is the Paul Merriman Foundation ETF recommendation for SCV. I think it is a good idea to obtain information/opinions from different sources.
The stock component of my portfolio is a combination of large, small, growth and value ETF’s utilizing low cost index funds. The SCV component is there for diversification and not necessarily to beat the market, but to be happy with what the market gives over time.
Regards Grant
Hi Grant
I looked at you tube and the Merriman recommendations. But I beg to differ with you. I am not impressed with projections, no matter how well-regarded the source. Analyst and advisor recommendations are confirmed just about 50% of the time (chance). I would suggest we stick with the numbers l. AVUV’s performance was impressive from its inception through the year before last. Last year it performed better than only 53% of similar funds (i.e, hardly more than chance) and so far this year it has trailed other small cap value funds by a wide margin (lowest 8%!). The numbers over the next few years will reveal whether what we saw a few years ago was just chance and now reverting to the mean (average) or whether the recent poor performance is really the blip and the fund will return to its earlier performance near the top of the pack. The data are what we need to look at, not even a well-regarded observer’s predictions.
Jonathan, please check that. I just remembered (at 80 my short-term memory isn’t what it used to be!)there is one I’m following and looks interesting. It’s the T. Rowe Price Capital Appreciation ETF (TCAF). It’s run by David Giroux, who has earned kudos from Morningstar for his success with his mutual fund with the same name.Miraculously, he is down only 2% this year although he is fully domestic and has a fair amount of tech.
Steve, if you’re looking for some to research, try T. Rowe Price Dividend Growth (TDVG) and Fidelity Total Bond (FBND).
Thanks, I definitely will.